Addiction journal
Addiction journal
Health claims about US cannabis products with Tim Mackey and Doug Roehler
Health claims about US cannabis products with Tim Mackey and Doug Roehler
Health claims about US cannabis products with Tim Mackey and Doug Roehler
Friday 28th November 2025
Explore cannabis product health claims with experts Tim Mackey & Doug Roehler in this insightful episode of Addiction Audio.
22 minutes
Informative
Eye-opening
Authentic
Educational
Honest
About this podcast
Author:
Addiction journal
Overview:
Categories:
Navigating Alcohol Dependency
Understanding Addiction & Recovery
Navigating Intimate Relationships
Family Recovery from Addiction
Nutritional Pathways to Recovery
Links:
Visit site
Episodes:
108 (View all)
Do you want to link to this podcast?
Get the buttons here!Unpacking Health Claims of US Cannabis Products
Episode Overview
- Cannabis products often carry multiple health claims without FDA approval.
- Online marketplaces like Leafly and Weedmaps are key platforms for cannabis sales.
- Regulating cannabis health claims is challenging due to varying state laws.
- Consumers often perceive benefits from cannabis despite lack of scientific validation.
- Collaboration between data scientists and public health experts is crucial.
"You're likely going to be exposed to a product that has a health claim associated with it."
Curious about how cannabis products in the US are marketed with health claims? Dr Elle Wadsworth sits down with Dr Tim Mackey and Dr Doug Roehler to unpack their fascinating research on this very topic. Tim, a professor at UC San Diego, and Doug, leading the Cannabis Research Unit in California, reveal the intricacies of health claims associated with cannabis products sold online.
From pain management to treating serious conditions like cancer, these claims often lack scientific backing and raise eyebrows about regulation. With platforms like Leafly and Weedmaps serving as major marketplaces, the discussion highlights the challenges of regulating these claims amidst varying state laws. You'll hear about the surprising scope of health claims and how they could potentially mislead consumers. The episode is a goldmine for anyone interested in the intersection of public health, cannabis use, and regulatory science.
It’s a riveting look at how consumers perceive benefits despite the lack of FDA approval, sparking questions about authenticity and the future of cannabis regulation. If you're intrigued by the complexities of cannabis marketing and its impact on public health, this episode is a must-listen.